Welcome to “signed sealed weekend”, our inside track on what’s happening in the Swiss legal market. Without further ado, let’s go through our news highlights of the week. In January 2025, Laurent Killias (pictured
Search Results for: VISCHER
Walder Wyss advised the Jacobs Foundation, an organization supporting child development and evidence-based education, as well as professional investment firm Jacobs Holding, in their transition from an intertwined setup to two independent institutions. The context
Vischer advised Swissroc Asset Management in connection with Swissroc Industrial Opportunities’ acquisition of a 4,200 m² light industrial building in the commune of Thônex (Geneva) from a professional investor. The 1991 building sits within the industrial
Vischer advised Mosanna Therapeutics in connection with its USD 80m Series A funding round. Headquartered in Basel, Switzerland, the clinical-stage biotech company, is working on a nighttime nasal spray to treat obstructive sleep apnea (OSA).
Vischer advised Thommen Group in connection with the acquisition of 100% of the shares in Wiederkehr Recycling, AVO Wiederkehr, SMV Wiederkehr Recycling and the companies Wierec Trading and Wierec Services GmbH (Waltenschwil AG), also belonging to
Vischer advised the Swissphone Group on the sale of certain assets and agreements of the Imasys business to F24 Schweiz. In connection with the deal, private equity firm Rigeto Unternehmerkapital advised the Swissphone Group as
Vischer advised the co-lead and other new investors in Aktiia’s oversubscribed USD 42m Series-B funding-round. Pursuant to the transaction, the blood pressure intelligence platform reached a total funding of USD 100m to date. The
Vischer advised GlycoEra in connection with its financing round. The Swiss biotechnology company, closed a USD 130 million Series B funding. BGPartner advised the lead investor Novo Holdings and new investor LifeArc Ventures on all Swiss
Walder Wyss advised Swiss laboratory and in-process solutions specialist Buchi Labortechnik on its acquisition of the NeoSpectra platform from Si-Ware Systems. The object of the transaction encompasses Si-Ware Systems’ handheld NIR analyzer and the NeoSpectra
Vischer advised the Matignon Group on its acquisition of 100% of the shares of Meon Clinic and Meon Center, based in Lucerne and Meggen. The company Headquartered in Paris, aesthetic medicine and surgery specialist Matignon Group
